The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma
2010 ◽
Vol 46
(2)
◽
pp. 212-221
◽
2018 ◽
Keyword(s):
2016 ◽
Vol 212
(2)
◽
pp. 238-245
◽
Keyword(s):
2014 ◽
Vol 10
(2)
◽
pp. 65-73
◽